Hormone FGF21 reverses fatty liver disease by signaling the brain
A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) can reverse ...
Tag: Fibrosis
Scientists engineer new drug candidate to fight deadly mycobacterial infection
In a classic example of scientific problem solving, scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) and ...
Existing therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy
A new study led by researchers at Hospital for Special Surgery (HSS) suggests that currently available therapies may help control ...
Serum hsa_circ_101555 as a promising biomarker for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of ...
Owlstone Medical announces investment of up to $2.3 million USD from the Cystic Fibrosis Foundation to develop a breath test for Pseudomonas aeruginosa detection in cystic fibrosis patients
Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced ...
Owlstone Medical secures investment from Cystic Fibrosis Foundation
Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced ...
Insilico Medicine's AI-driven drug Rentosertib receives official generic name
Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, recently announced that its breakthrough drug candidate for idiopathic ...
Health organizations collaborate to address idiopathic pulmonary fibrosis on Rare Disease Day 2025
The American College of Chest Physicians (CHEST), the PF Warriors, the Rare Disease Diversity Coalition (RDDC)-a program at the Black ...
Vitamin E significantly improves liver health in MASH patients, new study finds
New research shows that Vitamin E therapy significantly enhances liver function and reduces inflammation in MASH patients, providing a safer ...
Tampere University licenses drug for Epidermolysis Bullosa to Theravia
Tampere University has licensed a drug molecule intended for treating Epidermolysis Bullosa (EB), a group of rare and severe skin ...